- Home
- Publications
- Publication Search
- Publication Details
Title
Malignancies and thalassemia: a review of the literature
Authors
Keywords
-
Journal
Annals of the New York Academy of Sciences
Volume 1368, Issue 1, Pages 140-148
Publisher
Wiley
Online
2016-02-26
DOI
10.1111/nyas.13005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepcidin Regulation in Prostate and Its Disruption in Prostate Cancer
- (2015) Lia Tesfay et al. CANCER RESEARCH
- Pathogen inactivation
- (2015) Steven Kleinman CURRENT OPINION IN HEMATOLOGY
- The first case of breast cancer in thalassemic patient: case report and review of literature
- (2015) E. Picardo et al. GYNECOLOGICAL ENDOCRINOLOGY
- Incidence of Hepatocellular Carcinoma Reduced by Phlebotomy Treatment in Patients with Chronic Hepatitis C
- (2015) Kazushige Nirei et al. INTERNAL MEDICINE
- Thalassaemia and risk of cancer: a population-based cohort study
- (2015) Wei-Sheng Chung et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- Role of Sex Hormones in the Development and Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma
- (2015) Maurizio Montella et al. International Journal of Endocrinology
- Red cell transfusion and the immune system
- (2014) S. Hart et al. ANAESTHESIA
- Renal cell carcinoma in adult patients with thalassaemia major: a description of three cases
- (2014) Paolo Ricchi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry
- (2014) Caterina Borgna-Pignatti et al. BRITISH JOURNAL OF HAEMATOLOGY
- Transfusional Iron Overload and Iron Chelation Therapy in Thalassemia Major and Sickle Cell Disease
- (2014) Maria Marsella et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Implication of human herpesviruses in oncogenesis through immune evasion and supression
- (2014) Kenneth Alibek et al. Infectious Agents and Cancer
- Labile iron in cells and body fluids: physiology, pathology, and pharmacology
- (2014) Zvi Ioav Cabantchik Frontiers in Pharmacology
- Transfusion immunomodulation from a clinical perspective: an update
- (2013) Majed A Refaai et al. Expert Review of Hematology
- Renal aspects of thalassaemia a changing paradigm
- (2012) Sunil Bhandari et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Malignancies in β-Thalassemia Patients: First Description of Two Cases of Thyroid Cancer and Review of the Literature
- (2011) Maurizio Poggi et al. HEMOGLOBIN
- Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel
- (2010) V. Di Marco et al. BLOOD
- Incidence of Hepatocellular Carcinoma in a Thalassemia Unit
- (2010) Soso Fragatou et al. HEMOGLOBIN
- A Calcified Mass in the Spinal Canal of a Patient With β-thalassemia Major
- (2010) Caterina Borgna-Pignatti et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone
- (2009) P. T. Telfer et al. HAEMATOLOGICA
- Reduced serum hepcidin levels in patients with chronic hepatitis C
- (2009) Domenico Girelli et al. JOURNAL OF HEPATOLOGY
- Malignancies in patients with β-thalassemia major and β-thalassemia intermedia: A multicenter study in Iran
- (2009) Mehran Karimi et al. PEDIATRIC BLOOD & CANCER
- Decreased Cancer Risk After Iron Reduction in Patients With Peripheral Arterial Disease: Results From a Randomized Trial
- (2008) L. R. Zacharski et al. JNCI-Journal of the National Cancer Institute
- Malignancies in β-thalassemia patients: a single-center experience and a concise review of the literature
- (2007) L. BENETATOS et al. International Journal of Laboratory Hematology
- Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
- (2007) Giovanna Fattovich et al. JOURNAL OF HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More